Perimeter Institute for Theoretical Physics
14 meetings with public office holders, Jun 17, 2025 to May 21, 2026.
16 meetings on record since 2024, their first on record.
Meetings over time
- Jun 2025: 1 meeting, with Holly Duggan, Mark Emes
- Jul 2025: 1 meeting, with Mark Schaan, Manuela Tomic, David MacFarlane
- Aug 2025: 0 meetings
- Sep 2025: 0 meetings
- Oct 2025: 0 meetings
- Nov 2025: 8 meetings, with Taleeb Noormohamed, Ben Lobb, Francis Bilodeau, Nipun Vats, Peter Fragiskatos
- Dec 2025: 0 meetings
- Jan 2026: 0 meetings
- Feb 2026: 0 meetings
- Mar 2026: 0 meetings
- Apr 2026: 0 meetings
- May 2026: 4 meetings, with Philip Jennings, Nipun Vats, Mitch Davies
Jun 2025peak 8 in a monthMay 2026
Hover or focus a month to see who was met.
What they lobby about
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Liberal4 met · 4 meetings
Conservative2 met · 2 meetings
Not in Arena's member list10 met · 13 meetings
- Nipun Vats
- Manuela Tomic
- Damien O'Brian
- David MacFarlane
- Francis Bilodeau
- Holly Duggan
- Mark Emes
- Mark Schaan
- Mitch Davies
- Philip Jennings
Innovation, Science and Economic Development Canada (ISED) (10) · House of Commons (8) · National Research Council (NRC) (1)
In their own words
- Lobbying activities relate to federal policy, funding, and strategic priorities connected to foundational scientific research. Discussions may include the Strategic Science Fund, federal research support mechanisms, Canada’s innovation and research ecosystem, talent attraction, and the role of long-term discovery research in supporting national priorities in quantum, AI, and advanced technologies.
- Discuss policies and programs related to Canadian economic developmetn as it relates to funding research and development institutes and initiatives.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.